The contrasting relationships between betaine and homocysteine in two clinical cohorts are associated with plasma lipids and drug treatments

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Lever, Michael ^a,b   George, Peter M ^a,b   Atkinson, Wendy ^a   Elmslie, Jane L ^a   Slow, Sandy ^a,b   Molyneux, Sarah L ^a   Troughton, Richard W ^b   Richards, A Mark ^b   Frampton, Christopher M ^b   Chambers, Stephen T ^b  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAINE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL ESTER; CLOPIDOGREL; DIMETHYLGLYCINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG; CHOLESTEROL;

ACUTE CORONARY SYNDROME; ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BETAINE EXCRETION; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SEX DIFFERENCE; URINARY EXCRETION; BIOLOGICAL MODEL; BLOOD; HOSPITALIZATION; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; URINE; VASCULAR DISEASE;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BETAINE; CHOLESTEROL; COHORT STUDIES; FEMALE; HOMOCYSTEINE; HOSPITALIZATION; HUMANS; LIPID METABOLISM DISORDERS; LIPIDS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; VASCULAR DISEASES;

EID: 84857696397     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032460     Document Type: Article

References (30)

1. Lever M, Slow S, (2010) The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem 43: 732-744.
2. Ueland PM, (2011) Choline and betaine in health and disease. J Inherit Metab Dis 34: 3-15.
3. Craig SAS, (2004) Betaine in human nutrition. Am J Clin Nutr 80: 539-549.
4. Ueland PM, Holm PI, Hustad S, (2005) Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med 43: 1069-1075.
5. Konstantinova SV, Tell GS, Vollset SE, Nygård O, Bleie Ø, et al. (2008) Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr 138: 914-920.
6. Lever M, George PM, Dellow WJ, Scott RS, Chambers ST, (2005) Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic. Metabolism 54: 1-14.
7. Lever M, Atkinson W, Sizeland PCB, Chambers ST, George PM, (2007) Inter- and intra-individual variations in normal urinary glycine betaine excretion. Clin Biochem 40: 447-453.
8. Lever M, Atkinson W, George PM, Chambers ST, (2007) Sex differences in the control of plasma concentrations and urinary excretion of glycine betaine in patients attending a lipid disorders clinic. Clin Biochem 40: 1225-1231.
9. Strakova J, Williams KT, Gupta S, Schalinske KL, Kruger WD, et al. (2010) Dietary intake of S-(δ-carboxybutyl)-DL-homocysteine induces hyperhomocysteinemia in rats. Nutr Res 30: 492-500.
10. Teng Y-W, Mehedint MG, Garrow TA, Zeisel SH, (2011) Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas. J Biol Chem 286: 36258-36267.
11. Lever M, George PM, Atkinson W, Molyneux SL, Elmslie JL, et al. (2011) Plasma lipids and betaine are related in an Acute Coronary Syndrome Cohort. PLoS ONE 6: e21666.
12. Storer MK, (2006) Development of laboratory tests for assessing vitamin status. PhD Thesis, University of Otago, Dunedin, New Zealand. Available:http://hdl.handle.net/10523/2091.
13. Lever M, George PM, Slow S, Elmslie JL, Scott RS, et al. (2009) Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine. Cardiovasc Drugs Ther 23: 395-401.
14. Lever M, Slow S, George PM, Chambers ST, (2012) Betaine excretion correlates with plasma homocysteine when plasma lipids are elevated, Clin Biochem 45: 154-156.
15. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, et al. (2001) The prognostic value of B-type natriuretic peptides in patients with acute coronary syndromes. New Engl Med J 345: 1014-1021.
16. Storer MK, Lever M, (2006) Aracyl triflates for preparing fluorescent and UV absorbing derivatives of unreactive carboxylates, amines and other metabolites. Anal Chim Acta 558: 319-325.
17. Storer MK, McEntyre CJ, Lever M, (2006) Separation of cationic aracyl derivatives of betaines and related compounds. J Chromatog A 1104: 263-271.
18. Ueland PM, Clarke R, (2007) Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power. Clin Chem 53: 807-809.
19. Herrmann W, Herrmann M, Obeid R, (2007) Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab 8: 17-31.
20. de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, et al. (2009) Use of framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. Brit Med J 338: a3083.
21. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, et al. (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. New Engl J Med 354: 1578-1588.
22. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. New Engl J Med 354: 1567-1577.
23. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, et al. (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 299: 2027-2036.
24. Smulders YM, Blom HJ, (2011) The homocysteine controversy. J Inherit Metab Dis 34: 93-99.
25. Wald DS, Morris JK, Wald NJ, (2011) Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis. PLoS One 6 (2): e16473.
26. Holm PI, Bleie Ø, Ueland PM, Lien EA, Refsum H, et al. (2004) Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation. Arterioscler Thromb Vasc Biol 24: 301-307.
27. Slow S, Lever M, Chambers ST, George PM, (2009) Plasma dependent and independent accumulation of betaine in male and female rat tissues. Physiol Res 58: 403-410.
28. Lever M, Sizeland PC, Bason LM, Hayman CM, Robson RA, et al. (1994) Abnormal glycine betaine content of the blood and urine of diabetic and renal patients. Clin Chim Acta 230: 69-79.
29. Dellow WJ, Chambers ST, Lever M, Lunt H, Robson RA, (1999) Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia. Diab Res Clin Pract 43: 91-99.
30. Kim S, Yang S, Kim H, Kim Y, Park T, et al. (2009) 1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet. Anal Bioanal Chem 395: 1117-1124.